Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Canc...(eevents or otherwise. Contact: For...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Date:8/19/2007
e events or otherwise.
Contact:
For Indevus
Michael W. Rogers
Executive Vice President and CFO
(781) 861-8444
Brooke D. Wagner
VP, Corporate Communications,
(781) 402-3410
'/>"/>
SOURCE Indevus Pharmaceuticals, Inc. Copyright©2007 PR Newswire. |
Related medicine technology :
1. Indevus Announces Presentation of Pagoclone Data at 47th Annual New Clinical Drug Evaluation Unit Meeting
2. Indevus Reports Positive Data From Phase III NEBIDO Trial
3. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
4. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
5. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
6. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
7. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
8. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
9. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
10. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
11. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
Post Your Comments:
Breaking Medicine Technology:Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2NIA Says Health Care Will Cause U S Dollar Collapse 50998 1NIA Says Health Care Will Cause U S Dollar Collapse 50998 2NIA Says Health Care Will Cause U S Dollar Collapse 50998 3Why Do African Americans Fare Worse With Cancer 3F Access and Economics Are Only Part of the Story 4697 1Why Do African Americans Fare Worse With Cancer 3F Access and Economics Are Only Part of the Story 4697 2Why Do African Americans Fare Worse With Cancer 3F Access and Economics Are Only Part of the Story 4697 3Dietary supplements manufacturers gain new tool to help ensure quality products 9150 1Dietary supplements manufacturers gain new tool to help ensure quality products 9150 2
Other Medicine Technology:Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders 2Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 2Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 3Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 4Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients 5
Breaking Medicine News(10 mins):Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 2Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 3Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 2Health News:Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health 3
[0] White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices [1] NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus[1] Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765[1] Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas[0] Health Care Without Harm Applauds EPA Finding Climate Change is Danger to Public Health
Other Medicine News:Health News:A Honey of a Sinusitis Treatment 2Health News:A Honey of a Sinusitis Treatment 3Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 2Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 3Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 4Health News:New Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing Diagnosis 5Health News:Message to Los Angeles Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 2Health News:Message to Los Angeles Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight 3Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 2Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 3Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 4Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 5Health News:change:healthcare CEO Releases 'My Healthcare is Killing Me' 2Health News:American Beverage Association Statement on Caffeinated Energy Drinks 2
A Honey of a Sinusitis TreatmentNew Alzheimer's Disease Survey Reveals Disparities Between Beliefs and Behavior in Pursuing DiagnosisMessage to Los Angeles Residents: Forgo Fad Dieting and Join the Campaign for Healthy WeightLeapfrog Group's 2008 Top Hospitals Excel at Patient Safetychange:healthcare CEO Releases 'My Healthcare is Killing Me'American Beverage Association Statement on Caffeinated Energy Drinks
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |